nach oben

Erschienen in:

01.06.2011 | Main topic/CME

Role of echocardiography in cancer care

verfasst von: J.K. Raikhelkar, R.M. Steingart, C.L. Chen

Erschienen in: Herz | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

For cancer therapy survivors, regular echocardiographic follow-up of left ventricular function is considered part of standard care. Metastases of tumors on the pericardium and myocardium as well as cardiac structure and function can be assessed using echocardiography. This review focuses on current and developing echocardiographic modalities for the assessment of cardiac structure and function in the cancer patient, delineates the echocardiographic diagnosis of cardiac amyloidosis, and discusses the echocardiographic features of cardiac masses including those associated with the hypercoagulable state of cancer.

Anonymous (2010) HERCEPTIN (package insert). In: Genentech I (ed) San Francisco

Bellavia D, Pellikka PA, Abraham TP et al (2008) Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am J Cardiol 101:1039–1045PubMedCrossRef

Bellavia D, Pellikka PA, Al-Zahrani GB et al (2010) Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study. J Am Soc Echocardiogr 23:643–652PubMedCrossRef

Bu’Lock FA, Mott MG, Oakhill A et al (1995) Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology. Br Heart J 73:340–350CrossRef

Cardinale D, Colombo A, Lamantia G et al (2010) Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol 55:213–220PubMedCrossRef

Chu TF, Rupnick MA, Kerkela R et al (2007) Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet 370:2011–2019PubMedCrossRef

Comen EA, Fornier MN (2010) Algorithms for the treatment of patients with metastatic breast cancer and prior exposure to taxanes and anthracyclines. Clin Breast Cancer 10(Suppl 2):S7–S19PubMedCrossRef

Cueto-Garcia L, Reeder GS, Kyle RA et al (1985) Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 6:737–743PubMedCrossRef

Galper SL, Yu JB, Mauch PM et al (2011) Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood 117:412–418PubMedCrossRef

10.

Ganame J, Claus P, Uyttebroeck A et al (2007) Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients. J Am Soc Echocardiogr 20:1351–1358PubMedCrossRef

11.

Geyer H, Caracciolo G, Abe H et al (2010) Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr 23:351–369; quiz 453–355PubMedCrossRef

12.

Hare JL, Brown JK, Leano R et al (2009) Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am Heart J 158:294–301PubMedCrossRef

13.

Heidenreich PA, Hancock SL, Lee BK et al (2003) Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 42:743–749PubMedCrossRef

14.

Hensley ML, Hagerty KL, Kewalramani T et al (2009) American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 27:127–145PubMedCrossRef

15.

Jenkins C, Bricknell K, Hanekom L et al (2004) Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol 44:878–886PubMedCrossRef

16.

Jurcut R, Wildiers H, Ganame J et al (2008) Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer. J Am Soc Echocardiogr 21:1283–1289PubMedCrossRef

17.

Klein AL, Hatle LK, Taliercio CP et al (1991) Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation 83:808–816PubMed

18.

Koyama J, Ray-Sequin PA, Falk RH (2003) Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107:2446–2452PubMedCrossRef

19.

Kristen AV, Meyer FJ, Perz JB et al (2005) Risk stratification in cardiac amyloidosis: novel approaches. Transplantation 80:S151–S155PubMedCrossRef

20.

Mackey JR, Clemons M, Cote MA et al (2008) Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group. Curr Oncol 15:24–35PubMedCrossRef

21.

Myrehaug S, Pintilie M, Tsang R et al (2008) Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy. Leuk Lymphoma 49:1486–1493PubMedCrossRef

22.

Palladini G, Merlini G (2011) Transplantation vs. conventional-dose therapy for amyloidosis. Curr Opin Oncol 23:214–220PubMedCrossRef

23.

Piccart-Gebhart M, Procter M, Leyland-Jones B et al (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353:1659–1672PubMedCrossRef

24.

Rahman JE, Helou EF, Gelzer-Bell R et al (2004) Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 43:410–415PubMedCrossRef

25.

Schwartz RG, McKenzie WB, Alexander J et al (1987) Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med 82:1109–1118PubMedCrossRef

26.

Seidman A, Hudis C, Pierri MK et al (2002) Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 20:1215–1221PubMedCrossRef

27.

Selvanayagam JB, Hawkins PN, Paul B et al (2007) Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 50:2101–2110PubMedCrossRef

28.

Shankar SM, Marina N, Hudson MM et al (2008) Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children’s Oncology Group. Pediatrics 121:e387–e396PubMedCrossRef

29.

Soliman OI, Kirschbaum SW, Dalen BM van et al (2008) Accuracy and reproducibility of quantitation of left ventricular function by real-time three-dimensional echocardiography versus cardiac magnetic resonance. Am J Cardiol 102:778–783PubMedCrossRef

30.

Tan-Chiu E, Yothers G, Romond E et al (2005) Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. J Clin Oncol 23:7811–7819PubMedCrossRef

31.

Trachtenberg BH, Landy DC, Franco VI et al (2011) Anthracycline-associated cardiotoxicity in survivors of childhood cancer. Pediatr Cardiol 32:342–353PubMedCrossRef

32.

Tsang W, Lang RM (2010) Echocardiographic evaluation of cardiac amyloid. Curr Cardiol Rep 12:272–276PubMedCrossRef

33.

Yeh ET, Bickford CL (2009) Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol 53:2231–2247PubMedCrossRef

Titel: Role of echocardiography in cancer care
verfasst von: J.K. Raikhelkar
R.M. Steingart
C.L. Chen
Publikationsdatum: 01.06.2011
Verlag: Urban and Vogel
Erschienen in: Herz / Ausgabe 4/2011
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-011-3443-6

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Role of echocardiography in cancer care

Abstract

Neu im Fachgebiet Kardiologie

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Kardiologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

Tumormarker im Perikarderguss bei malignen und nichtmalignen Perikardergüssen

Assessment of cardiotoxicity with cardiac biomarkers in cancer patients

Cardiac side effects of conventional and particle radiotherapy in cancer patients

Neuregulin in heart failure

Mechanisms and management of doxorubicin cardiotoxicity

Sorafenib-associated multivessel coronary artery vasospasm

Neu im Fachgebiet Kardiologie

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Kardiologie